ipilimumab,sunitinib,nivolumab,cabozantinib
bms,pfizer
['sunitinib', 'rcc,(-irccs),(-srcc),(-urcc)', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'check,mate,9er', 'cabo ', 'nivo']
4 year follow up data for 9er cabo/nivo vs sunitinib in rcc. rr, pfs impressive &amp; similar to previous cuts. os relatively stable: hr 0.70. tox remain ok. os in good risk looks the same as sunitinib (hr-1) but rr higher for combo. debate around good risk treatment is complex #gu23 
Interested in Urology Cancers, biomarkers and drug development.